The Rising Prevalence of Infectious Diseases and Rising Number of Cases of Different Types of Cancer is Expected to Boost the Growth of the Global Molecular Diagnostics Market at a CAGR of 5.70% During the Forecast Period 2025 to 2035

The Rising Prevalence of Infectious Diseases and Rising Number of Cases of Different Types of Cancer is Expected to Boost the Growth of the Global Molecular Diagnostics Market at a CAGR of 4.42% During the Forecast Period 2025 to 2035

Market Research Future (MRFR) has published a cooked research report on the “Global Molecular Diagnostics Market” that contains the information from 2019 to 2035. The Molecular Diagnostics market is estimated to register a CAGR of 4.42% during the forecast period of 2025 to 2035.

MRFR recognizes the following companies as the key players in the Global Molecular Diagnostics Market — Roche Diagnostics (CH), Abbott Laboratories (US), Thermo Fisher Scientific (US), Siemens Healthineers (DE), Danaher Corporation (US), BioMérieux (FR), Qiagen (NL), Hologic (US), and PerkinElmer (US).

Market Highlights

The Global Molecular Diagnostics Market is accounted for to register a CAGR of 4.42% during the forecast period and is estimated to reach USD 28.65 Billion by 2035.

The market growth is fueled by technological advancements, rising demand for personalized medicine, and an increasing prevalence of chronic and infectious diseases. The integration of next-generation sequencing (NGS), point-of-care testing (POCT), and artificial intelligence in diagnostics is reshaping the global healthcare landscape.

Advancements in genomic technologies have revolutionized diagnostic capabilities, improving accuracy and turnaround time for disease detection. Furthermore, the growing focus on preventive healthcare and early diagnosis continues to strengthen market expansion, as patients and healthcare providers increasingly seek proactive medical interventions.

Key industry developments highlight a surge in AI-powered molecular diagnostics, with companies such as Abbott, Roche, and Thermo Fisher Scientific leading innovation in automation and data-driven analysis. These breakthroughs are enabling precise disease detection, personalized treatment planning, and improved clinical outcomes.

Segment Analysis

The Global Molecular Diagnostics Market has been segmented based on Technology, Application, Product Type, and End-user.

• By Technology: The Polymerase Chain Reaction (PCR) segment held the largest market share in 2024 due to its reliability and efficiency in DNA amplification. Meanwhile, Next-Generation Sequencing (NGS) is the fastest-growing segment, driven by its ability to conduct comprehensive genomic analyses and support precision medicine.


• By Application: Oncology dominated the market in 2024, owing to the increasing prevalence of cancer and the demand for accurate genetic profiling in treatment. The Infectious Diseases segment is projected to grow at the fastest rate, particularly in the Asia-Pacific region, driven by the need for rapid diagnostic tools during global health crises.


• By Product Type: Reagents accounted for the largest revenue share due to their indispensable role in molecular testing. However, Instruments are emerging rapidly with innovations in automation and compact diagnostic devices.


• By End-user: Hospitals held the largest market share in 2024, leveraging molecular diagnostics for disease management and treatment personalization. Diagnostic Laboratories, however, are the fastest-growing end-user category, attributed to increasing outsourcing of specialized molecular tests.

Region Analysis

By region, the Molecular Diagnostics Market is segmented into North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

• North America leads the global market, holding approximately 45% share, backed by robust R&D investments, regulatory support from the U.S. FDA, and the presence of key players such as Roche, Abbott, and Thermo Fisher. The U.S. remains the growth engine for the region.


• Europe accounts for around 30% of the global market, supported by the implementation of the In Vitro Diagnostic Regulation (IVDR) and increasing demand for early and accurate disease detection. Germany, France, and the UK lead regional growth through innovation and collaboration.


• Asia-Pacific is the fastest-growing region, driven by rising healthcare expenditure, supportive government policies, and expanding access to advanced diagnostics in countries like China, India, and Japan.


• Middle East and Africa represent emerging markets, gaining traction through increased healthcare investments and improved diagnostic infrastructure, with South Africa and the UAE being key contributors.

Key Findings of the Study

• The Global Molecular Diagnostics Market is expected to reach USD 28.65 Billion by 2035, at a CAGR of 4.42% during the forecast period.


• North America accounted for the largest market share in 2024.


• Based on Technology, PCR held the largest market share, while NGS is projected to grow fastest.


• Based on Application, Oncology dominated the market, with Infectious Diseases growing rapidly.


• Roche Diagnostics, Abbott Laboratories, Thermo Fisher Scientific, Siemens Healthineers, Danaher Corporation, BioMérieux, Qiagen, Hologic, and PerkinElmer are the key players shaping the market.

Related Reports:

Molecular Diagnostics Market Size, Growth Statistics 2035